Atlas Trials

Feasibility Study of Adjuvant Treatment With S-1 and Oxaliplatin in Patients With Resectable Esophageal Cancer

Clinical trial NCT02347904 · COMPLETED

Trial details

NCT number
NCT02347904
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Esophageal Cancer
Start date
2014-12-01
Primary completion
2019-11-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.